NeuroOne Medical Technologies (NMTC) Competitors $1.00 +0.06 (+5.99%) As of 10:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NMTC vs. RCEL, NYXH, MBOT, LNSR, LAKE, SPAI, PROF, INO, LUCD, and HYPRShould you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Avita Medical (RCEL), Nyxoah (NYXH), Microbot Medical (MBOT), LENSAR (LNSR), Lakeland Industries (LAKE), Safe Pro Group (SPAI), Profound Medical (PROF), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. NeuroOne Medical Technologies vs. Its Competitors Avita Medical Nyxoah Microbot Medical LENSAR Lakeland Industries Safe Pro Group Profound Medical Inovio Pharmaceuticals Lucid Diagnostics Hyperfine Avita Medical (NASDAQ:RCEL) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations. Does the media favor RCEL or NMTC? In the previous week, Avita Medical had 5 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Avita Medical and 0 mentions for NeuroOne Medical Technologies. Avita Medical's average media sentiment score of 0.14 beat NeuroOne Medical Technologies' score of 0.00 indicating that Avita Medical is being referred to more favorably in the media. Company Overall Sentiment Avita Medical Neutral NeuroOne Medical Technologies Neutral Do analysts rate RCEL or NMTC? Avita Medical currently has a consensus target price of $11.60, suggesting a potential upside of 111.91%. NeuroOne Medical Technologies has a consensus target price of $2.23, suggesting a potential upside of 122.50%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Avita Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avita Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RCEL or NMTC more profitable? NeuroOne Medical Technologies has a net margin of -55.44% compared to Avita Medical's net margin of -68.87%. NeuroOne Medical Technologies' return on equity of -163.49% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avita Medical-68.87% -632.62% -71.52% NeuroOne Medical Technologies -55.44%-163.49%-78.67% Do institutionals & insiders believe in RCEL or NMTC? 27.7% of Avita Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, RCEL or NMTC? Avita Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Which has better earnings and valuation, RCEL or NMTC? NeuroOne Medical Technologies has lower revenue, but higher earnings than Avita Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvita Medical$64.25M2.27-$61.85M-$1.97-2.78NeuroOne Medical Technologies$3.45M14.49-$12.32M-$0.15-6.67 SummaryAvita Medical and NeuroOne Medical Technologies tied by winning 8 of the 16 factors compared between the two stocks. Get NeuroOne Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTC vs. The Competition Export to ExcelMetricNeuroOne Medical TechnologiesMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.05M$7.72B$5.72B$10.39BDividend YieldN/A2.76%5.53%4.58%P/E Ratio-6.6774.1976.1626.62Price / Sales14.4934.62471.8492.08Price / CashN/A23.0337.4661.85Price / Book33.336.8613.336.46Net Income-$12.32M$245.04M$3.29B$271.49M7 Day Performance15.61%1.62%2.29%2.97%1 Month Performance27.45%2.46%4.44%7.56%1 Year Performance0.57%10.38%75.18%30.09% NeuroOne Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTCNeuroOne Medical Technologies2.2322 of 5 stars$1.00+6.0%$2.23+122.5%+0.0%$50.05M$3.45M-6.6720Gap UpRCELAvita Medical2.4223 of 5 stars$6.25-7.5%$11.60+85.6%-48.4%$166.37M$74.88M-3.17130High Trading VolumeNYXHNyxoah2.5877 of 5 stars$4.65-2.5%$15.00+222.6%-43.1%$158.38M$4.89M-2.02110News CoverageMBOTMicrobot Medical2.3228 of 5 stars$3.34-2.3%$12.00+259.3%+309.4%$152.14MN/A-5.7620Analyst DowngradeGap UpLNSRLENSAR0.9004 of 5 stars$12.35+0.1%$15.00+21.5%+184.4%$147.40M$58.36M-2.93110LAKELakeland Industries4.8661 of 5 stars$14.59+0.7%$25.00+71.4%-26.3%$139.63M$167.21M-5.322,100Analyst DowngradeSPAISafe Pro Group3.3074 of 5 stars$7.20-2.8%$10.50+45.8%+141.0%$135.43M$2.17M-9.0011Positive NewsUpcoming EarningsPROFProfound Medical1.726 of 5 stars$4.04-1.2%$11.00+172.3%-32.9%$121.69M$11.84M-2.77150News CoverageINOInovio Pharmaceuticals3.7766 of 5 stars$2.28flat$8.80+286.0%-59.0%$121.16M$220K-0.87320LUCDLucid Diagnostics2.7757 of 5 stars$1.07+0.9%$3.65+241.1%+35.3%$116.07M$4.35M-0.9070HYPRHyperfine1.0859 of 5 stars$1.41+1.4%$1.28-9.0%+39.0%$110.80M$12.89M-2.71190 Related Companies and Tools Related Companies RCEL Competitors NYXH Competitors MBOT Competitors LNSR Competitors LAKE Competitors SPAI Competitors PROF Competitors INO Competitors LUCD Competitors HYPR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTC) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts